Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02995397

Ligand	Ligand name	Chain	PDB	Tanimoto
AO5		A	1R58	0.72
ICL	[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER	A	1INC	0.7
PNM	OPEN FORM - PENICILLIN G	A	1GHP	0.7
PNM	OPEN FORM - PENICILLIN G	A	1PWC	0.7
PNM	OPEN FORM - PENICILLIN G	A	1IYQ	0.7
PNM	OPEN FORM - PENICILLIN G	A	1FQG	0.7
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2J8Y	0.7
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2JBF	0.7
PNM	OPEN FORM - PENICILLIN G	A	2EX8	0.7
PG1	PENICILLIN G ACYL-SERINE	A,B	1XA7	0.72
PG1	PENICILLIN G ACYL-SERINE	A	2IWC	0.72
PG1	PENICILLIN G ACYL-SERINE	A,B	1MWT	0.72
153	(2S)-2-[(2,4-DICHLORO-BENZOYL)-(3-TRIFLUOROMETHYL-BENZYL)-AMINO]-3-PHENYL-PROPIONIC ACID	A,B	1NHU	0.74
SP9	N-{(1R)-3-[(4-aminobutyl)amino]-1-methylpropyl}benzamide	A,B	3CNT	0.71
BSA	2-(BENZOYLAMINO)ETHANESULFONIC ACID	A	1YQS	0.71
CLD	D-PARA-CHLOROPHENYL-1-ACTEAMIDOBORONIC ACID ALANINE	A	1AVT	0.7
TI1	[2(R,S)-2-SULFANYLHEPTANOYL]-PHE-ALA	A	1R1I	0.7
TI1	[2(R,S)-2-SULFANYLHEPTANOYL]-PHE-ALA	A	1QF1	0.7
CLB	D-PARA-CHLOROPHENYL-1-ACETAMIDOBORONIC ACID ALANINE	A	1VSB	0.7
S2D	N-BENZOYL-D-ALANINE	A,B	2JCI	0.78
BM5	(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER	A	1C0U	0.71
TIN		A,B	1N94	0.75
LAZ	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	A,B	1OJC	0.8
SP8	N-{(1S)-3-[(4-aminobutyl)amino]-1-methylpropyl}benzamide	A,B	3CNS	0.71
B30	{2,2'-[(2-{[4-(AMINOSULFONYL)BENZOYL]AMINO}ETHYL)IMINO]DIACETATO(2-)-KAPPAO}COPPER	A	2FOV	0.7
B30	{2,2'-[(2-{[4-(AMINOSULFONYL)BENZOYL]AMINO}ETHYL)IMINO]DIACETATO(2-)-KAPPAO}COPPER	A,B	2FOY	0.7
19U	1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide	H,I	2ZFP	0.7
ICX	methyl N-[(5Z)-6-({[4-(4-iodobenzyl)phenyl]carbonyl}amino)hex-5-enoyl]glycinate	A,C,D,E,G,P,Q,R,W	3CWB	0.72
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SN9	0.73
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1SNE	0.73
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SNA	0.73
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1XOF	0.73
CS4	S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE	A	2OQZ	0.74
CRP	((1RS,3SR)-2,2-DICHLORO-N-[(R)-1-(4-CHLOROPHENYL)ETHYL]-1-ETHYL-3-METHYLCYCLOPROPANECARBOXAMIDE	A	2STD	0.71
CRP	((1RS,3SR)-2,2-DICHLORO-N-[(R)-1-(4-CHLOROPHENYL)ETHYL]-1-ETHYL-3-METHYLCYCLOPROPANECARBOXAMIDE	A,B,C	7STD	0.71
TR1	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	A,B	1C8T	0.72
TR1	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	A,B	1C3I	0.72
G23	(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	A	1HTE	0.72
P21	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	A	2VD4	0.72